Home
TA
Companies
Products
Deals
KOL opinions
Register
中文
Log in
LinkedBio 订阅服务
您的亚洲医药市场情报与创新药合作伙伴
获取创新药项目资讯、医药市场数据及专业商务对接服务,助力企业发现全球医药合作机会
LinkedBio Report core
LinkedBio Database
View all current and archived reports
View all current and archived newsletters
View all current and archived webinars
Search by year, topic, keywords
View non-confidential slides for report/product
TA
Companies
Products
Deals
KOL Opinions
USD 599/year
USD 25,000/year
LinkedBio Report Premium: USD 5,000 / year, up to 5 initial LinkedBio partnering services as below:
- View non-confidential slides for project evaluation purposes (within 5 working days upon request)
- View Lingmed expert’s initial evaluation score card with preliminary analysis (within 5 working days upon request)
- Direct initial introduction by Lingmed to the interested biotech companies with the innovative asset (within 5 working days upon request)
Disclaimer: Please note Lingmed team will make the best-effort connection for you to meet with the asset company, but there is no guarantee that the other party will accept such partnering meeting. Once a partnering request has been triggered, one credit will be deducted, regardless of the partnering results.
LinkedBio Report core
LinkedBio Report premium
View all current and archived reports
View all current and archived newsletters
View all current and archived webinars
Search by year, topic, keywords
Up to 5 initial LinkedBio partnering services as below:
View non-confidential slides for project evaluation purposes (within 5 working days upon request)
View Lingmed expert’s initial evaluation score card with preliminary analysis (within 5 working days upon request)
Direct initial introduction by Lingmed to the interested biotech companies with the innovative asset (within 5 working days upon request)
USD 599/year
USD 5599/year
Disclaimer: Please note Lingmed team will make the best-effort connection for you to meet with the asset company, but there is no guarantee that the other party will accept such partnering meeting. Once a partnering request has been triggered, one credit will be deducted, regardless of the partnering results.
订阅方案与服务对比服务内容
核心报告版
※ 高级报告及项目对接版
专业数据库版
最新及历史研究报告
最新及历史行业通讯
最新及历史网络研讨会
按年份、主题及关键词搜索
项目非保密资料获取
—
灵麦专家初步项目评估
—
—
创新药企业初步商务对接
—
—
治疗领域(TA)数据库
—
—
医药企业数据库
—
—
药物及研发产品数据库
—
—
医药交易数据库
—
—
KOL专家观点
—
—
每年项目对接额度
—
5次
—
年度订阅价格
USD 599
USD 5,000
USD 25,000
※ 高级报告及项目对接版
USD 5,000/年|包含5次初步项目对接服务
每次项目对接服务包含以下三个环节,不分别扣除服务额度
1. 项目非保密资料获取
根据客户指定的创新药项目,协助获取相关非保密资料(Non-confidential Slides),用于初步项目评估
服务标准:收到申请后5个工作日内提供已有资料或反馈获取进展
2. 灵麦专家初步项目评估
由灵麦医药专家提供项目初步评估评分表(Evaluation Scorecard),包括项目价值、开发阶段及潜在合作机会的初步分析
服务标准:收到申请及必要资料后5个工作日内提供初步评估
3. 创新药企业初步商务对接
根据客户指定的创新药项目,由灵麦医药联系相关企业,协助建立初步商务联系,并争取安排合作会议
服务标准:收到申请后5个工作日内启动对接,并反馈初步进展
服务额度及使用规则
1. 每个订阅年度包含最多5次初步项目对接服务
2. 每次针对一个指定创新药项目的正式对接申请计为1次额度
3. 每次对接服务包含上述三个环节,不分别扣除额度
4. 一旦正式启动项目对接,即扣除1次额度,无论最终是否成功安排会议或达成合作
5. 未使用的服务额度不自动结转至下一订阅年度
免责声明
灵麦医药将尽商业合理努力,协助客户联系目标创新药企业并推动初步商务交流
项目资料的获取及合作会议的安排取决于相关企业的配合与意愿。灵麦医药不保证目标企业一定接受会议邀请,也不保证最终达成商业合作
5个工作日为相应服务的响应或启动时限,不代表保证在该期限内成功安排合作会议
Register for a free trial
Subscribe